| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tandem Mass Spectrometry | 21 | 2019 | 60 | 2.060 |
Why?
|
| Environmental Exposure | 11 | 2015 | 91 | 1.430 |
Why?
|
| Chromatography, High Pressure Liquid | 14 | 2019 | 94 | 1.290 |
Why?
|
| Cotinine | 7 | 2018 | 49 | 1.180 |
Why?
|
| Smoking | 7 | 2018 | 528 | 1.060 |
Why?
|
| Trans Fatty Acids | 2 | 2017 | 10 | 0.990 |
Why?
|
| Nutritional Status | 2 | 2017 | 75 | 0.980 |
Why?
|
| United States | 30 | 2020 | 3976 | 0.920 |
Why?
|
| Disease Outbreaks | 3 | 2019 | 43 | 0.890 |
Why?
|
| Environmental Monitoring | 10 | 2014 | 28 | 0.880 |
Why?
|
| Nutrition Surveys | 7 | 2017 | 148 | 0.870 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2019 | 59 | 0.850 |
Why?
|
| Urinalysis | 5 | 2020 | 27 | 0.830 |
Why?
|
| Botulinum Toxins | 9 | 2012 | 38 | 0.830 |
Why?
|
| Nicotine | 3 | 2020 | 174 | 0.750 |
Why?
|
| Chromatography, Liquid | 11 | 2018 | 43 | 0.720 |
Why?
|
| Adult | 31 | 2020 | 9380 | 0.720 |
Why?
|
| Creatinine | 5 | 2019 | 195 | 0.720 |
Why?
|
| Peritoneal Dialysis | 3 | 2020 | 26 | 0.690 |
Why?
|
| Kidney Failure, Chronic | 4 | 2020 | 543 | 0.680 |
Why?
|
| Humans | 65 | 2020 | 32114 | 0.680 |
Why?
|
| Lung Injury | 1 | 2019 | 68 | 0.660 |
Why?
|
| Glucuronides | 1 | 2018 | 2 | 0.630 |
Why?
|
| Hypoglycins | 5 | 2018 | 5 | 0.620 |
Why?
|
| Middle Aged | 24 | 2020 | 11839 | 0.620 |
Why?
|
| Glycine | 5 | 2018 | 27 | 0.620 |
Why?
|
| Cyclopropanes | 5 | 2018 | 19 | 0.620 |
Why?
|
| Female | 37 | 2020 | 20015 | 0.610 |
Why?
|
| Tobacco Smoke Pollution | 5 | 2010 | 44 | 0.600 |
Why?
|
| Ultrafiltration | 1 | 2017 | 11 | 0.590 |
Why?
|
| Nitrosamines | 4 | 2010 | 11 | 0.590 |
Why?
|
| Hypotension | 1 | 2017 | 47 | 0.570 |
Why?
|
| Fasting | 1 | 2017 | 95 | 0.560 |
Why?
|
| Dietary Fats | 1 | 2017 | 110 | 0.550 |
Why?
|
| Young Adult | 11 | 2020 | 2665 | 0.550 |
Why?
|
| Diet | 3 | 2017 | 391 | 0.540 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 9 | 2012 | 27 | 0.540 |
Why?
|
| Male | 32 | 2020 | 19217 | 0.530 |
Why?
|
| Adolescent | 20 | 2020 | 3568 | 0.530 |
Why?
|
| Mass Spectrometry | 9 | 2017 | 102 | 0.520 |
Why?
|
| Pyridines | 3 | 2010 | 76 | 0.520 |
Why?
|
| Hyperkalemia | 1 | 2015 | 15 | 0.520 |
Why?
|
| Hypoglycemia | 1 | 2015 | 45 | 0.510 |
Why?
|
| Hematinics | 1 | 2014 | 6 | 0.490 |
Why?
|
| Organic Chemicals | 2 | 2011 | 7 | 0.490 |
Why?
|
| Environmental Pollutants | 4 | 2014 | 21 | 0.490 |
Why?
|
| Solid Phase Extraction | 4 | 2014 | 4 | 0.480 |
Why?
|
| Renal Dialysis | 1 | 2017 | 282 | 0.480 |
Why?
|
| Glucose | 1 | 2015 | 174 | 0.470 |
Why?
|
| Anemia | 1 | 2014 | 58 | 0.470 |
Why?
|
| Aged | 16 | 2020 | 10314 | 0.460 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2014 | 28 | 0.460 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 5 | 2011 | 5 | 0.450 |
Why?
|
| Immune Complex Diseases | 1 | 2013 | 2 | 0.440 |
Why?
|
| Insulin | 1 | 2015 | 367 | 0.440 |
Why?
|
| Antibodies, Antinuclear | 1 | 2013 | 18 | 0.440 |
Why?
|
| Hematuria | 1 | 2012 | 11 | 0.430 |
Why?
|
| Lupus Nephritis | 1 | 2013 | 30 | 0.430 |
Why?
|
| Lactobacillus | 1 | 2012 | 14 | 0.430 |
Why?
|
| Patient Compliance | 1 | 2014 | 225 | 0.420 |
Why?
|
| European Continental Ancestry Group | 4 | 2012 | 1166 | 0.420 |
Why?
|
| Endopeptidases | 5 | 2012 | 26 | 0.410 |
Why?
|
| Blood Chemical Analysis | 6 | 2020 | 22 | 0.360 |
Why?
|
| Amino Acid Sequence | 16 | 2017 | 285 | 0.360 |
Why?
|
| Reproducibility of Results | 9 | 2019 | 765 | 0.360 |
Why?
|
| Proteomics | 5 | 2016 | 94 | 0.330 |
Why?
|
| Antigens, Bacterial | 4 | 2011 | 18 | 0.330 |
Why?
|
| Trypsin | 4 | 2017 | 11 | 0.320 |
Why?
|
| Child | 13 | 2017 | 2442 | 0.320 |
Why?
|
| Cataract | 1 | 2008 | 8 | 0.320 |
Why?
|
| Carcinogens | 5 | 2010 | 35 | 0.320 |
Why?
|
| Fruit | 3 | 2018 | 53 | 0.310 |
Why?
|
| Zinc | 1 | 2008 | 32 | 0.310 |
Why?
|
| Macular Degeneration | 1 | 2008 | 22 | 0.310 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 109 | 0.300 |
Why?
|
| Antioxidants | 1 | 2008 | 115 | 0.300 |
Why?
|
| Influenza Vaccines | 4 | 2014 | 78 | 0.290 |
Why?
|
| Viral Proteins | 3 | 2014 | 35 | 0.290 |
Why?
|
| Sapindus | 2 | 2018 | 2 | 0.290 |
Why?
|
| Reference Values | 6 | 2019 | 246 | 0.290 |
Why?
|
| Molecular Sequence Data | 13 | 2014 | 359 | 0.280 |
Why?
|
| Hypertension | 1 | 2014 | 960 | 0.280 |
Why?
|
| Ricin | 3 | 2011 | 4 | 0.280 |
Why?
|
| Antibodies, Monoclonal | 4 | 2011 | 246 | 0.260 |
Why?
|
| Bacterial Toxins | 3 | 2011 | 23 | 0.250 |
Why?
|
| Apolipoproteins | 2 | 2018 | 200 | 0.250 |
Why?
|
| Public Health | 2 | 2011 | 89 | 0.250 |
Why?
|
| Information Services | 1 | 2005 | 15 | 0.250 |
Why?
|
| Maternal Exposure | 1 | 2004 | 10 | 0.250 |
Why?
|
| Peptides | 6 | 2012 | 120 | 0.240 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 90 | 0.230 |
Why?
|
| Age Factors | 7 | 2013 | 1189 | 0.230 |
Why?
|
| Sensitivity and Specificity | 6 | 2020 | 582 | 0.220 |
Why?
|
| Sex Factors | 5 | 2013 | 667 | 0.220 |
Why?
|
| Tobacco | 3 | 2010 | 57 | 0.220 |
Why?
|
| Retrospective Studies | 3 | 2017 | 3510 | 0.220 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2020 | 9 | 0.220 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 3 | 2017 | 28 | 0.220 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2017 | 19 | 0.200 |
Why?
|
| Vesicle-Associated Membrane Protein 2 | 2 | 2011 | 2 | 0.200 |
Why?
|
| Magnesium Deficiency | 1 | 2020 | 1 | 0.190 |
Why?
|
| Hemoglobins | 2 | 2014 | 49 | 0.190 |
Why?
|
| Magnesium | 1 | 2020 | 30 | 0.190 |
Why?
|
| Apolipoprotein B-100 | 2 | 2018 | 10 | 0.180 |
Why?
|
| Apolipoprotein A-I | 2 | 2018 | 68 | 0.180 |
Why?
|
| Sapindaceae | 2 | 2018 | 2 | 0.180 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2011 | 33 | 0.180 |
Why?
|
| Asthma | 1 | 2002 | 259 | 0.180 |
Why?
|
| Vitamin E | 1 | 2019 | 23 | 0.170 |
Why?
|
| Substance Abuse Detection | 1 | 2019 | 8 | 0.170 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2019 | 12 | 0.170 |
Why?
|
| Catheterization | 1 | 2020 | 58 | 0.170 |
Why?
|
| Catheters, Indwelling | 1 | 2020 | 43 | 0.170 |
Why?
|
| Reverse Transcriptase Inhibitors | 2 | 2009 | 7 | 0.170 |
Why?
|
| Acute Lung Injury | 1 | 2019 | 33 | 0.170 |
Why?
|
| Fentanyl | 1 | 2019 | 32 | 0.170 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 2 | 2009 | 3 | 0.170 |
Why?
|
| Neurotoxins | 2 | 2012 | 16 | 0.170 |
Why?
|
| Insecticides | 3 | 2004 | 21 | 0.170 |
Why?
|
| Phospholipids | 1 | 2019 | 28 | 0.170 |
Why?
|
| Cholesterol | 2 | 2018 | 252 | 0.160 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 876 | 0.160 |
Why?
|
| Urine | 1 | 2019 | 65 | 0.160 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 3990 | 0.160 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 55 | 0.160 |
Why?
|
| African Continental Ancestry Group | 3 | 2010 | 363 | 0.160 |
Why?
|
| Dyslipidemias | 1 | 2019 | 53 | 0.160 |
Why?
|
| Anthrax | 2 | 2009 | 5 | 0.160 |
Why?
|
| Fractionation, Field Flow | 1 | 2018 | 1 | 0.160 |
Why?
|
| Calibration | 5 | 2019 | 28 | 0.160 |
Why?
|
| Lipids | 2 | 2018 | 232 | 0.150 |
Why?
|
| Laparoscopy | 1 | 2020 | 172 | 0.150 |
Why?
|
| Lipoproteins | 1 | 2018 | 86 | 0.150 |
Why?
|
| Botulism | 3 | 2012 | 9 | 0.150 |
Why?
|
| Hydrogenation | 1 | 2017 | 1 | 0.150 |
Why?
|
| Blood Glucose | 2 | 2020 | 494 | 0.140 |
Why?
|
| Litchi | 1 | 2017 | 1 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 232 | 0.140 |
Why?
|
| Isotope Labeling | 3 | 2011 | 16 | 0.140 |
Why?
|
| Smoke | 2 | 2009 | 16 | 0.140 |
Why?
|
| Cohort Studies | 2 | 2020 | 1817 | 0.140 |
Why?
|
| Influenza A virus | 2 | 2014 | 22 | 0.140 |
Why?
|
| Triglycerides | 1 | 2017 | 230 | 0.140 |
Why?
|
| Occupational Exposure | 3 | 2004 | 232 | 0.140 |
Why?
|
| Quality Control | 3 | 2018 | 44 | 0.130 |
Why?
|
| Feeding Behavior | 1 | 2017 | 161 | 0.130 |
Why?
|
| Clostridium botulinum | 2 | 2012 | 3 | 0.130 |
Why?
|
| Prevalence | 1 | 2018 | 989 | 0.130 |
Why?
|
| Pregnancy | 3 | 2014 | 997 | 0.120 |
Why?
|
| Neuraminidase | 2 | 2011 | 10 | 0.120 |
Why?
|
| Ethnic Groups | 4 | 2013 | 476 | 0.120 |
Why?
|
| Linear Models | 3 | 2018 | 449 | 0.120 |
Why?
|
| Child, Preschool | 5 | 2009 | 1270 | 0.120 |
Why?
|
| Sex Distribution | 2 | 2014 | 191 | 0.120 |
Why?
|
| Erythropoietin | 1 | 2014 | 30 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2020 | 780 | 0.120 |
Why?
|
| Cross-Sectional Studies | 4 | 2014 | 1542 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 308 | 0.120 |
Why?
|
| Influenza in Birds | 1 | 2014 | 3 | 0.120 |
Why?
|
| Animals | 12 | 2015 | 7542 | 0.120 |
Why?
|
| Incidence | 2 | 2015 | 1199 | 0.120 |
Why?
|
| Substrate Specificity | 5 | 2012 | 87 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 2017 | 399 | 0.120 |
Why?
|
| Phenols | 1 | 2014 | 17 | 0.120 |
Why?
|
| California | 2 | 2004 | 63 | 0.110 |
Why?
|
| Health Surveys | 1 | 2014 | 198 | 0.110 |
Why?
|
| Child Development | 1 | 2014 | 43 | 0.110 |
Why?
|
| Trace Elements | 1 | 2013 | 7 | 0.110 |
Why?
|
| Nutrition Policy | 1 | 2013 | 35 | 0.110 |
Why?
|
| Reagent Strips | 1 | 2012 | 4 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2014 | 92 | 0.110 |
Why?
|
| Bacterial Proteins | 2 | 2010 | 90 | 0.110 |
Why?
|
| False Positive Reactions | 1 | 2012 | 29 | 0.110 |
Why?
|
| Vitamins | 1 | 2013 | 68 | 0.110 |
Why?
|
| Atrazine | 1 | 2012 | 1 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2005 | 672 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1428 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 12 | 0.100 |
Why?
|
| Lead | 2 | 2009 | 6 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 2265 | 0.100 |
Why?
|
| Reference Standards | 4 | 2019 | 32 | 0.100 |
Why?
|
| Beverages | 1 | 2011 | 19 | 0.100 |
Why?
|
| Castor Bean | 1 | 2011 | 1 | 0.100 |
Why?
|
| Toxicology | 1 | 2011 | 6 | 0.090 |
Why?
|
| Plant Proteins | 1 | 2011 | 13 | 0.090 |
Why?
|
| Clostridium | 1 | 2010 | 4 | 0.090 |
Why?
|
| Software | 1 | 2011 | 123 | 0.090 |
Why?
|
| Tars | 1 | 2010 | 3 | 0.090 |
Why?
|
| Risk | 1 | 2012 | 321 | 0.090 |
Why?
|
| Chemical Warfare Agents | 1 | 2011 | 14 | 0.090 |
Why?
|
| Polychlorinated Biphenyls | 3 | 2009 | 7 | 0.090 |
Why?
|
| Immunoglobulin G | 2 | 2012 | 122 | 0.090 |
Why?
|
| Risk Factors | 2 | 2017 | 3880 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2014 | 923 | 0.090 |
Why?
|
| Glycosuria | 2 | 2020 | 3 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 684 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2011 | 61 | 0.090 |
Why?
|
| Limit of Detection | 3 | 2018 | 15 | 0.090 |
Why?
|
| Polyphosphates | 1 | 2009 | 1 | 0.090 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2009 | 4 | 0.090 |
Why?
|
| Registries | 2 | 2020 | 298 | 0.090 |
Why?
|
| Principal Component Analysis | 2 | 2020 | 68 | 0.090 |
Why?
|
| Polyglutamic Acid | 1 | 2009 | 1 | 0.090 |
Why?
|
| Biochemistry | 1 | 2009 | 1 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2014 | 845 | 0.080 |
Why?
|
| Nucleotides | 1 | 2009 | 16 | 0.080 |
Why?
|
| Nucleosides | 1 | 2009 | 10 | 0.080 |
Why?
|
| Lead Poisoning | 1 | 2009 | 3 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 66 | 0.080 |
Why?
|
| Air Pollution | 1 | 2009 | 18 | 0.080 |
Why?
|
| Air Pollutants | 1 | 2009 | 24 | 0.080 |
Why?
|
| Isotopes | 3 | 2017 | 11 | 0.080 |
Why?
|
| Socioeconomic Factors | 3 | 2006 | 429 | 0.080 |
Why?
|
| Conjunctivitis | 1 | 2008 | 3 | 0.080 |
Why?
|
| Micronutrients | 1 | 2008 | 18 | 0.080 |
Why?
|
| Complex Mixtures | 1 | 2008 | 3 | 0.080 |
Why?
|
| Antigens, Viral | 1 | 2008 | 21 | 0.080 |
Why?
|
| Pneumococcal Infections | 1 | 2008 | 31 | 0.080 |
Why?
|
| Streptococcus pneumoniae | 1 | 2008 | 40 | 0.080 |
Why?
|
| Orthomyxoviridae | 1 | 2008 | 14 | 0.080 |
Why?
|
| Infant | 3 | 2009 | 1062 | 0.080 |
Why?
|
| Regression Analysis | 2 | 2005 | 293 | 0.070 |
Why?
|
| Anthrax Vaccines | 1 | 2007 | 4 | 0.070 |
Why?
|
| Thyroid Hormones | 1 | 2006 | 5 | 0.070 |
Why?
|
| Proteins | 1 | 2008 | 144 | 0.070 |
Why?
|
| Mexican Americans | 1 | 2006 | 60 | 0.070 |
Why?
|
| Disease Progression | 1 | 2008 | 594 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 1176 | 0.070 |
Why?
|
| Feces | 1 | 2006 | 38 | 0.070 |
Why?
|
| Logistic Models | 2 | 2006 | 783 | 0.070 |
Why?
|
| Milk | 1 | 2005 | 16 | 0.070 |
Why?
|
| Xenobiotics | 1 | 2005 | 1 | 0.060 |
Why?
|
| Population | 1 | 2005 | 8 | 0.060 |
Why?
|
| Nervous System | 1 | 2005 | 13 | 0.060 |
Why?
|
| Harm Reduction | 1 | 2004 | 14 | 0.060 |
Why?
|
| Fetal Death | 1 | 2004 | 9 | 0.060 |
Why?
|
| Maternal Age | 1 | 2004 | 15 | 0.060 |
Why?
|
| Pyrenes | 1 | 2004 | 1 | 0.060 |
Why?
|
| Demography | 1 | 2005 | 110 | 0.060 |
Why?
|
| Community Health Centers | 1 | 2004 | 16 | 0.060 |
Why?
|
| Counseling | 1 | 2004 | 97 | 0.060 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2004 | 8 | 0.060 |
Why?
|
| Macaca mulatta | 3 | 2011 | 305 | 0.060 |
Why?
|
| Air Pollutants, Occupational | 1 | 2003 | 4 | 0.060 |
Why?
|
| Terrorism | 1 | 2003 | 3 | 0.060 |
Why?
|
| Behavior Therapy | 1 | 2004 | 103 | 0.060 |
Why?
|
| Fires | 1 | 2003 | 6 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 1128 | 0.060 |
Why?
|
| Selenium | 1 | 2003 | 4 | 0.050 |
Why?
|
| Methyl Parathion | 1 | 2002 | 1 | 0.050 |
Why?
|
| Nitrophenols | 1 | 2002 | 3 | 0.050 |
Why?
|
| Child Welfare | 1 | 2002 | 21 | 0.050 |
Why?
|
| Decision Making | 1 | 2005 | 195 | 0.050 |
Why?
|
| Health Status | 1 | 2005 | 400 | 0.050 |
Why?
|
| Health Education | 1 | 2002 | 163 | 0.050 |
Why?
|
| Veterans | 1 | 2002 | 68 | 0.050 |
Why?
|
| Parents | 1 | 2002 | 147 | 0.050 |
Why?
|
| Renal Tubular Transport, Inborn Errors | 1 | 2020 | 1 | 0.050 |
Why?
|
| Polyuria | 1 | 2020 | 3 | 0.050 |
Why?
|
| Hypothyroidism | 1 | 2020 | 12 | 0.050 |
Why?
|
| Terpenes | 1 | 2020 | 7 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2012 | 60 | 0.040 |
Why?
|
| Dialysis Solutions | 1 | 2020 | 6 | 0.040 |
Why?
|
| Mouth | 1 | 2020 | 25 | 0.040 |
Why?
|
| Hispanic Americans | 2 | 2005 | 940 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 56 | 0.040 |
Why?
|
| Smoking Cessation | 1 | 2002 | 210 | 0.040 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2011 | 23 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2019 | 21 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 198 | 0.040 |
Why?
|
| Urea | 1 | 2019 | 37 | 0.040 |
Why?
|
| Age Distribution | 2 | 2010 | 206 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2020 | 1429 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 517 | 0.040 |
Why?
|
| Plant Poisoning | 1 | 2018 | 1 | 0.040 |
Why?
|
| Inhalation | 2 | 2009 | 8 | 0.040 |
Why?
|
| Seeds | 1 | 2018 | 10 | 0.040 |
Why?
|
| Scattering, Radiation | 1 | 2018 | 5 | 0.040 |
Why?
|
| Mice | 3 | 2010 | 2484 | 0.040 |
Why?
|
| Workflow | 1 | 2018 | 21 | 0.040 |
Why?
|
| Light | 1 | 2018 | 24 | 0.040 |
Why?
|
| Particle Size | 1 | 2018 | 46 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2017 | 35 | 0.040 |
Why?
|
| Cholesterol Esters | 1 | 2017 | 36 | 0.040 |
Why?
|
| Hydrocarbons, Chlorinated | 2 | 2009 | 4 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2018 | 175 | 0.040 |
Why?
|
| India | 1 | 2017 | 61 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2016 | 19 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 472 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 294 | 0.030 |
Why?
|
| Birds | 1 | 2014 | 3 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 898 | 0.030 |
Why?
|
| Pesticides | 2 | 2009 | 199 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 70 | 0.030 |
Why?
|
| Financing, Government | 1 | 2014 | 11 | 0.030 |
Why?
|
| Acetylation | 1 | 2012 | 15 | 0.030 |
Why?
|
| Drug Stability | 1 | 2012 | 8 | 0.030 |
Why?
|
| Guanidine | 1 | 2012 | 3 | 0.030 |
Why?
|
| Gels | 1 | 2012 | 31 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2011 | 3 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2014 | 548 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2011 | 17 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 62 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2011 | 65 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 75 | 0.020 |
Why?
|
| Nucleoproteins | 1 | 2011 | 1 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2011 | 9 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 1596 | 0.020 |
Why?
|
| Plant Lectins | 1 | 2011 | 1 | 0.020 |
Why?
|
| DNA Probes | 1 | 2011 | 19 | 0.020 |
Why?
|
| Clostridium botulinum type F | 1 | 2010 | 1 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2011 | 58 | 0.020 |
Why?
|
| SNARE Proteins | 1 | 2010 | 4 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 91 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2010 | 5 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2010 | 13 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 435 | 0.020 |
Why?
|
| Rabbits | 1 | 2011 | 197 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 252 | 0.020 |
Why?
|
| Lamivudine | 1 | 2009 | 2 | 0.020 |
Why?
|
| Adenine | 1 | 2009 | 16 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2011 | 122 | 0.020 |
Why?
|
| Ricinus | 1 | 2009 | 1 | 0.020 |
Why?
|
| Indicator Dilution Techniques | 1 | 2009 | 2 | 0.020 |
Why?
|
| Hemagglutinins | 1 | 2009 | 4 | 0.020 |
Why?
|
| Clostridium botulinum type A | 1 | 2009 | 1 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2009 | 27 | 0.020 |
Why?
|
| Reassortant Viruses | 1 | 2009 | 1 | 0.020 |
Why?
|
| Analytic Sample Preparation Methods | 1 | 2009 | 1 | 0.020 |
Why?
|
| Serotyping | 1 | 2009 | 19 | 0.020 |
Why?
|
| Glycosylation | 1 | 2009 | 15 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 49 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 56 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2009 | 68 | 0.020 |
Why?
|
| Virulence | 1 | 2009 | 22 | 0.020 |
Why?
|
| Sweden | 1 | 2009 | 14 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2009 | 32 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 99 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 130 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 149 | 0.020 |
Why?
|
| Streptococcus oralis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Streptococcus mitis | 1 | 2008 | 2 | 0.020 |
Why?
|
| Enterococcus faecalis | 1 | 2008 | 12 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2008 | 17 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2008 | 20 | 0.020 |
Why?
|
| Neutrophils | 1 | 2009 | 106 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2008 | 41 | 0.020 |
Why?
|
| Streptococcus pyogenes | 1 | 2008 | 16 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 125 | 0.020 |
Why?
|
| Proteome | 1 | 2008 | 39 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2008 | 53 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2008 | 87 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2007 | 11 | 0.020 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2008 | 47 | 0.020 |
Why?
|
| Antibodies | 1 | 2007 | 52 | 0.020 |
Why?
|
| Bacillus anthracis | 1 | 2007 | 9 | 0.020 |
Why?
|
| Exotoxins | 1 | 2007 | 13 | 0.020 |
Why?
|
| Travel | 1 | 2007 | 15 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2006 | 8 | 0.020 |
Why?
|
| Thyroxine | 1 | 2006 | 16 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 169 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 153 | 0.020 |
Why?
|
| Mass Screening | 1 | 2009 | 263 | 0.020 |
Why?
|
| Benzofurans | 1 | 2005 | 4 | 0.020 |
Why?
|
| Mercury | 1 | 2005 | 6 | 0.020 |
Why?
|
| Metals | 1 | 2005 | 18 | 0.020 |
Why?
|
| Occupations | 1 | 2004 | 10 | 0.020 |
Why?
|
| Polymers | 1 | 2005 | 64 | 0.020 |
Why?
|
| Mutagens | 1 | 2003 | 3 | 0.010 |
Why?
|
| Hydrocarbons | 1 | 2003 | 2 | 0.010 |
Why?
|
| New York City | 1 | 2003 | 14 | 0.010 |
Why?
|
| Metals, Heavy | 1 | 2003 | 7 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 61 | 0.010 |
Why?
|
| Mothers | 1 | 2004 | 88 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 881 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 525 | 0.010 |
Why?
|
| Insect Control | 1 | 2002 | 1 | 0.010 |
Why?
|
| United States Environmental Protection Agency | 1 | 2002 | 2 | 0.010 |
Why?
|
| Geography | 1 | 2003 | 35 | 0.010 |
Why?
|
| Local Government | 1 | 2002 | 6 | 0.010 |
Why?
|
| Interinstitutional Relations | 1 | 2002 | 12 | 0.010 |
Why?
|
| State Government | 1 | 2002 | 32 | 0.010 |
Why?
|
| Data Collection | 1 | 2003 | 182 | 0.010 |
Why?
|
| Continental Population Groups | 1 | 2004 | 237 | 0.010 |
Why?
|
| Italy | 1 | 2002 | 15 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2002 | 17 | 0.010 |
Why?
|
| Accidents, Occupational | 1 | 2002 | 16 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 2151 | 0.010 |
Why?
|